{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:45:01Z","timestamp":1788281101242,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02076-y","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:56:09Z","timestamp":1762779369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gut microbiota dysbiosis and short-chain fatty acid depletion in phlegm-dampness polycystic ovary syndrome: a cross-sectional 16S rRNA sequencing analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiao-Yan","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"2076_CR1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"2076_CR2","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, et al. International evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"issue":"3","key":"2076_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.xfnr.2021.03.003","volume":"2","author":"Y He","year":"2021","unstructured":"He Y, Jin X, Wang H, et al. The emerging role of the gut Microbiome in polycystic ovary syndrome. F&S Rev. 2021;2(3):214\u201326.","journal-title":"F&S Rev"},{"issue":"4","key":"2076_CR4","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1210\/jc.2017-02153","volume":"103","author":"PJ Torres","year":"2018","unstructured":"Torres PJ, Siakowska M, Banaszewska B, et al. Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism. J Clin Endocrinol Metab. 2018;103(4):1502\u201311.","journal-title":"J Clin Endocrinol Metab"},{"key":"2076_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12967-025-06315-7","volume":"23","author":"H Senthilkumar","year":"2025","unstructured":"Senthilkumar H, Arumugam M. Gut microbiota: a hidden player in polycystic ovary syndrome. J Transl Med. 2025;23:443.","journal-title":"J Transl Med"},{"key":"2076_CR6","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2147\/IJWH.S522708","volume":"17","author":"S Liu","year":"2025","unstructured":"Liu S, Cheng L, Li S. Characteristics of gut microbiota in patients with polycystic ovary syndrome and its association with metabolic abnormalities. Int J Women\u2019s Health. 2025;17:2165\u201374.","journal-title":"Int J Women\u2019s Health"},{"issue":"8","key":"2076_CR7","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","volume":"25","author":"X Qi","year":"2019","unstructured":"Qi X, Yun C, Sun L, et al. Gut microbiota\u2013bile acid\u2013interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25(8):1225\u201333.","journal-title":"Nat Med"},{"issue":"2","key":"2076_CR8","first-page":"546","volume":"102","author":"L Lindheim","year":"2017","unstructured":"Lindheim L, Bashir M, M\u00fcnzker J, et al. Alterations in gut Microbiome composition and barrier function are associated with reproductive and metabolic defects in women with PCOS. J Clin Endocrinol Metab. 2017;102(2):546\u201356.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2076_CR9","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1210\/jc.2017-02799","volume":"103","author":"M Insenser","year":"2018","unstructured":"Insenser M, Murri M, Del Campo R, et al. Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity. J Clin Endocrinol Metab. 2018;103(7):2552\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"2076_CR10","first-page":"1549499","volume":"15","author":"Y Guo","year":"2025","unstructured":"Guo Y, Qi Y, Yang X, Zhao L, Wen S, Liu Y. Gut microbiota dysbiosis in PCOS: novel insights into mechanisms and therapeutic potential. Front Microbiol. 2025;15:1549499.","journal-title":"Front Microbiol"},{"issue":"1","key":"2076_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12866-024-03513-z","volume":"24","author":"F Huang","year":"2024","unstructured":"Huang F, Deng Y, Zhou M, et al. Fecal microbiota transplantation from patients with PCOS induces metabolic disorders and ovarian dysfunction in germ-free mice. BMC Microbiol. 2024;24(1):364.","journal-title":"BMC Microbiol"},{"issue":"9","key":"2076_CR12","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325\u201340.","journal-title":"J Lipid Res"},{"issue":"6","key":"2076_CR13","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332\u201345.","journal-title":"Cell"},{"key":"2076_CR14","doi-asserted-by":"publisher","first-page":"1394873","DOI":"10.3389\/fcimb.2024.1394873","volume":"14","author":"S Dong","year":"2025","unstructured":"Dong S, Yao X, Jiao J, et al. Fecal propionate is a signature of insulin resistance in polycystic ovary syndrome. Front Cell Infect Microbiol. 2025;14:1394873.","journal-title":"Front Cell Infect Microbiol"},{"key":"2076_CR15","first-page":"1134569","volume":"14","author":"R Xie","year":"2023","unstructured":"Xie R, Sun Y, Wu J, et al. Altered gut microbiota and SCFAs in Chinese women with PCOS. Front Endocrinol (Lausanne). 2023;14:1134569.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"2076_CR16","first-page":"1048","volume":"36","author":"X Zhao","year":"2020","unstructured":"Zhao X, Jiang Y, Xi H, Chen L, Feng X. Exploration of the relationship between gut microbiota and PCOS with insulin resistance. Gynecol Endocrinol. 2020;36(11):1048\u201353.","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"2076_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","volume":"25","author":"X Qi","year":"2019","unstructured":"Qi X, Yun C, Sun L, et al. Gut microbiota\u2013bile acid\u2013IL-22 axis orchestrates PCOS. Nat Med. 2019;25(8):1225\u201333.","journal-title":"Nat Med"},{"key":"2076_CR18","first-page":"324","volume":"8","author":"R Liu","year":"2017","unstructured":"Liu R, Zhang C, Shi Y, et al. Dysbiosis of gut microbiota associated with clinical parameters in PCOS. Front Microbiol. 2017;8:324.","journal-title":"Front Microbiol"},{"key":"2076_CR19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12916-023-02947-y","volume":"21","author":"Y Wei","year":"2023","unstructured":"Wei Y, Wu Y, Zong Q, et al. Gut microbiota dysbiosis in PCOS: a systematic review and meta-analysis. BMC Med. 2023;21:240.","journal-title":"BMC Med"},{"key":"2076_CR20","doi-asserted-by":"publisher","first-page":"1524521","DOI":"10.3389\/fmicb.2024.1524521","volume":"15","author":"R Wu","year":"2025","unstructured":"Wu R, Mai Z, Song X, Zhao W. Hotspots and research trends of gut Microbiome in PCOS: a bibliometric analysis (2012\u20132023). Front Microbiol. 2025;15:1524521.","journal-title":"Front Microbiol"},{"issue":"6","key":"2076_CR21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11655-021-3525-0","volume":"28","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang X, Xu X, et al. Clinical characteristics and TCM syndrome distribution in PCOS: a multicenter survey. Chin J Integr Med. 2022;28(6):423\u201330.","journal-title":"Chin J Integr Med"},{"issue":"20","key":"2076_CR22","first-page":"2393","volume":"133","author":"X Li","year":"2020","unstructured":"Li X, Sun J, Chen C, et al. Characteristics of phlegm-dampness syndrome in PCOS: a cross-sectional analysis. Chin Med J (Engl). 2020;133(20):2393\u20139.","journal-title":"Chin Med J (Engl)"},{"key":"2076_CR23","doi-asserted-by":"crossref","first-page":"102721","DOI":"10.1016\/j.ctim.2021.102737","volume":"59","author":"Y Chen","year":"2021","unstructured":"Chen Y, Gao Q, Wang W, et al. Relationship between TCM syndromes and metabolic abnormalities in PCOS. Complement Ther Med. 2021;59:102721.","journal-title":"Complement Ther Med"},{"key":"2076_CR24","doi-asserted-by":"crossref","first-page":"1371543","DOI":"10.3389\/fcimb.2024.1371543","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liu J, Zhang H, et al. Effects of herbal formula Dingkun Dan on gut microbiota and metabolism in PCOS patients with phlegm-dampness. Front Cell Infect Microbiol. 2024;14:1371543.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"2076_CR25","first-page":"e176","volume":"20","author":"X Yang","year":"2020","unstructured":"Yang X, Wang Y, Chen R, et al. Electroacupuncture modulates gut microbiota and improves insulin sensitivity in PCOS. Clin Med (Lond). 2020;20(5):e176\u201382.","journal-title":"Clin Med (Lond)"},{"key":"2076_CR26","doi-asserted-by":"publisher","first-page":"6389034","DOI":"10.1155\/2020\/6389034","volume":"2020","author":"N Zhang","year":"2020","unstructured":"Zhang N, Li C, Guo Y, et al. Study on the intervention effect of Qi Gong Wan prescription on patients with phlegm-dampness syndrome of polycystic ovary syndrome based on intestinal flora. Evid Based Complement Alternat Med. 2020;2020:6389034.","journal-title":"Evid Based Complement Alternat Med"},{"key":"2076_CR27","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-117891\/v1","author":"Z Ni","year":"2020","unstructured":"Ni Z, Huang Y, Huang X, et al. Impact of Buzhong Yiqi prescription on the gut microbiota of obese patients with PCOS and phlegm-dampness syndrome caused by spleen deficiency. Res Sq. 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-117891\/v1.","journal-title":"Res Sq"},{"key":"2076_CR28","doi-asserted-by":"publisher","first-page":"859708","DOI":"10.3389\/fcimb.2022.859708","volume":"12","author":"J Shin","year":"2022","unstructured":"Shin J, et al. Obese individuals with and without phlegm-dampness constitution can be distinguished by gut microbiota characteristics. Front Cell Infect Microbiol. 2022;12:859708.","journal-title":"Front Cell Infect Microbiol"},{"issue":"23","key":"2076_CR29","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.3390\/nu16234196","volume":"16","author":"N Kim","year":"2024","unstructured":"Kim N, Kim JK. Butyrate as a potential modulator in gynecological diseases. Nutrients. 2024;16(23):4196.","journal-title":"Nutrients"},{"key":"2076_CR30","first-page":"e7590","volume":"103","author":"X Gao","year":"2024","unstructured":"Gao X, et al. Exploring the causal pathway from gut microbiota to PCOS via Mendelian randomization. Med (Baltim). 2024;103:e7590.","journal-title":"Med (Baltim)"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02076-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02076-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02076-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:10:01Z","timestamp":1762884601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-02076-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2076"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02076-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Institutional Ethics Committee of Hainan Women and Children\u2019s Medical Center vide letter No. HNWCMC2022 . All procedures were conducted in accordance with the Declaration of Helsinki (2013 revision), and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}